Albert Morales

Barcelona Biomedical Research Park — Spain

Medicine · Health Sciences

58h-index10.4kcitations189works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(27), Cancer, Hypoxia, and Metabolism(23), Sphingolipid Metabolism and Signaling(22), Phagocytosis and Immune Regulation(21), Peroxisome Proliferator-Activated Receptors(18)

Publications189 total

Correction: Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stages
Frontiers in Immunology·2026Open Access
Immune remodeling via mitochondria-dependent STING activation enhances cabozantinib response in hepatocellular carcinoma
Journal of Experimental & Clinical Cancer Research·2026Open Access
Additional file 3 of Immune remodeling via mitochondria-dependent STING activation enhances cabozantinib response in hepatocellular carcinoma
Figshare·2026Open Access
Additional file 2 of Immune remodeling via mitochondria-dependent STING activation enhances cabozantinib response in hepatocellular carcinoma
Figshare·2026Open Access
Additional file 1 of Immune remodeling via mitochondria-dependent STING activation enhances cabozantinib response in hepatocellular carcinoma
Figshare·2026Open Access
Immune remodeling via mitochondria-dependent STING activation enhances cabozantinib response in hepatocellular carcinoma
Figshare·2026Open Access
Additional file 1 of Immune remodeling via mitochondria-dependent STING activation enhances cabozantinib response in hepatocellular carcinoma
Figshare·2026Open Access
Immune remodeling via mitochondria-dependent STING activation enhances cabozantinib response in hepatocellular carcinoma
Figshare·2026Open Access
Additional file 3 of Immune remodeling via mitochondria-dependent STING activation enhances cabozantinib response in hepatocellular carcinoma
Figshare·2026Open Access
Additional file 2 of Immune remodeling via mitochondria-dependent STING activation enhances cabozantinib response in hepatocellular carcinoma
Figshare·2026Open Access
Picrosirius red, polarized light microscopy, and curvelet transform analysis: An improved method for liver fibrosis assessment
Tissue and Cell·2025Open Access
#3375 The alternative pathway of the renin angiotensin aldosterone system is overactivated in severe COVID-19 at baseline
Nephrology Dialysis Transplantation·2025Open Access
#2349 Increased baseline circulating ACE2 activity and Gas6 levels predict COVID-19 severity
Nephrology Dialysis Transplantation·2025
After Severe COVID-19 Infection Patients Show Normalization of ACE2 Activity and Gas6 Levels
Journal of the American Society of Nephrology·2025
Alternative Pathway of RAAS Is Basally Overactivated in Patients Diagnosed with Severe COVID-19
Journal of the American Society of Nephrology·2025
Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stages
Frontiers in Immunology·2025· 2 citedOpen Access
FRI-360 Sex-based differences in immune response and liver damage in MASLD-associated sepsis: role of neutrophil extracellular traps
Journal of Hepatology·2025
WCN25-1523 CIRCULATING ACE2 ACTIVITY IS INCREASED IN DIAGNOSED COVID-19 PATIENTS
Kidney International Reports·2025Open Access
RNA translational regulation by CPEB4 orchestrates platelet function and pathophysiology
2025Open Access
La vía alternativa del sistema renina-angiotensina-aldosterona se encuentra sobre activado basalmente en los pacientes diagnosticados de COVID-19 severo
DIGITAL.CSIC (Spanish National Research Council (CSIC))·2025
page 1 of 10Next →

Frequent Co-authors

José C. Fernández‐Checa(42), Carmen García‐Ruiz(36), Montserrat Marı́(35), Anna Colell(34), Neil Kaplowitz(9), Ana María Cameán Fernández(5), Merce Miranda(5), Esther Ardite(5), Laura Llacuna(5), Gorka Basáñez(5), Cristina de Dios(5), Vicente Roca‐Agujetas(5), Anna Tutusaus(5), Pablo Garcı́a de Frutos(5), Joan Montero(4), Josep M. Lluis(4), Oihana Terrones(4), Núria Tarrats(4), Anna Moles(4), Francisca G. Caballero(3)